Capital DailyCapital Daily
Finance

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?

Broader diversification or higher yield? Explore how these two healthcare ETFs stack up for different investor goals.

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?

Published June 18, 2026 · Category: Finance

Overview

Vanguard Health Care ETF (NYSEMKT:VHT) provides broad-spectrum medical sector exposure at a low cost, while VanEck Pharmaceutical ETF (NASDAQ:PPH) offers concentrated exposure to global pharmaceutical giants with a higher yield.

Investors seeking defensive exposure often turn to the medical sector, but choosing between a broad-market basket and a specialized industry play can significantly impact portfolio performance. This comparison analyzes a diversified giant with a concentrated pharmaceutical fund to help clarify which strategy aligns with specific income and growth objectives.

Details

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.